Exact Mass: 235.15722060000002

Exact Mass Matches: 235.15722060000002

Found 77 metabolites which its exact mass value is equals to given mass value 235.15722060000002, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CID 131801220

1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-yl)methyl]methanamine

C14H21NO2 (235.15722060000002)

Stovaine

1-[(dimethylamino)methyl]-1-methylpropyl benzoate

C14H21NO2 (235.15722060000002)

C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent Same as: D07454

N,N-Didesmethyltramadol

(1R,2R)-2-(aminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol

C14H21NO2 (235.15722060000002)

N,N-Didesmethyltramadol is a metabolite of tramadol. Tramadol hydrochloride (trademarked as Conzip, Ryzolt, Ultracet, Ultram in the USA; Ralivia and Zytram XL in Canada) is a centrally-acting synthetic analgesic used to treat moderate to moderately-severe pain. The drug has a wide range of applications, including treatment of rheumatoid arthritis, restless legs syndrome, and fibromyalgia. It was launched and marketed as Tramal by the German pharmaceutical company Grnenthal GmbH in 1977 (Wikipedia).

N,O-Didesmethyltramadol

3-[(1R,2R)-1-hydroxy-2-[(methylamino)methyl]cyclohexyl]phenol

C14H21NO2 (235.15722060000002)

N,O-Didesmethyltramadol is a metabolite of tramadol. Tramadol hydrochloride (trademarked as Conzip, Ryzolt, Ultracet, Ultram in the USA; Ralivia and Zytram XL in Canada) is a centrally-acting synthetic analgesic used to treat moderate to moderately-severe pain. The drug has a wide range of applications, including treatment of rheumatoid arthritis, restless legs syndrome, and fibromyalgia. It was launched and marketed as Tramal by the German pharmaceutical company Grnenthal GmbH in 1977 (Wikipedia).

N,N,O-Tridesmethylvenlafaxine

1-[2-Amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol

C14H21NO2 (235.15722060000002)

N,N,O-Tridesmethylvenlafaxine is a metabolite of venlafaxine (brand name: Effexor or Efexor). Venlafaxine is a bicyclic antidepressant and is usually categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI), but it has been referred to as a serotonin-norepinephrine-dopamine reuptake inhibitor. It works by blocking the transporter reuptake proteins for key neurotransmitters affecting mood, thereby leaving more active neurotransmitters in the synapse. N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3398 CONFIDENCE standard compound; INTERNAL_ID 2015

C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent